Mirum Pharmaceuticals (MIRM) Inventory (2021 - 2026)

Mirum Pharmaceuticals has reported Inventory for 6 years, with the latest figure at $25.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 13.83% year-over-year to $25.5 million; the trailing twelve-month figure through Mar 2026 stood at $25.5 million (up 13.83% YoY), and the FY2025 full-year result was $24.9 million, up 11.09% from the prior year.
• Inventory for Q1 2026 stood at $25.5 million, up from $24.9 million in the prior quarter.
• The five-year high for Inventory was $25.5 million in Q1 2026, with the low at $1.6 million in Q1 2022.
• Average Inventory over 5 years is $16.7 million, with a median of $21.6 million recorded in 2024.
• Year-over-year, Inventory surged 318.54% in 2023 and retreated 2.95% in 2024.
• Tracing MIRM's Inventory over 5 years: stood at $5.6 million in 2022, then jumped by 300.93% to $22.3 million in 2023, then gained by 0.41% to $22.4 million in 2024, then increased by 11.09% to $24.9 million in 2025, then rose by 2.54% to $25.5 million in 2026.
• The last three Inventory figures came in at $25.5 million (Q1 2026), $24.9 million (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.

Peer Comparison